#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3736	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2365	461.1	0	.	n	.	0	C207T	SNP	207	207	C	579	579	T	502	T,C	235,221	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3736	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2365	461.1	0	.	n	.	0	C451T	SNP	451	451	C	823	823	T	524	T,C,A	228,241,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3736	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2365	461.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1556	1556	C	539	C,T	481,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3736	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2365	461.1	0	HET	.	.	.	C1450T,A	.	1450	1450	C	1822	1822	C	506	C,T,A	241,238,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3736	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2365	461.1	0	HET	.	.	.	T84TCGGGTGGCG,TCG	.	84	84	T	456	456	T	520	TCGGGTGGCG,TCG	391,110	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5950	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4029	442.1	0	.	n	.	0	T695C	SNP	695	695	T	1294	1294	C	462	C,A	416,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5950	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4029	442.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2570	2570	C	526	C,T	468,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5950	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4029	442.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3196	3196	T	519	T	466	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5950	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4029	442.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2644	2644	A	537	A,G	492,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	536	folP	855	855	100.0	folP.l15.c4.ctg.1	2128	75.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1433	1435	AGC	115;115;117	A;G;C	102;107;108	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1208	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3964	91.4	1	SNP	p	S91F	1	.	.	271	273	TTC	896	898	TTC	112;112;111	T;T;C	100;101;105	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1208	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3964	91.4	1	SNP	p	G95N	0	.	.	283	285	GGC	908	910	GGC	109;108;108	G;G;C	100;100;99	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1208	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3964	91.4	1	SNP	p	D95G	1	.	.	283	285	GGC	908	910	GGC	109;108;108	G;G;C	100;100;99	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	566	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1769	95.5	1	SNP	p	G45D	0	.	.	133	135	GGC	720	722	GGC	144;144;144	G;G;C	132;133;138	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	356	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1645	65.0	0	.	n	.	0	A197.	DEL	197	197	A	851	851	A	133	A	122	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1232	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3447	107.0	1	SNP	p	D86N	0	.	.	256	258	GAC	767	769	GAC	139;139;140	G;A;C	114;112;117	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1232	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3447	107.0	1	SNP	p	R87I	0	.	.	259	261	CGT	770	772	CGT	140;139;139	C;G;T	118;116;115	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1232	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3447	107.0	1	SNP	p	S87R	1	.	.	259	261	CGT	770	772	CGT	140;139;139	C;G;T	118;116;115	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1232	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3447	107.0	1	SNP	p	R87W	0	.	.	259	261	CGT	770	772	CGT	140;139;139	C;G;T	118;116;115	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1232	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3447	107.0	1	SNP	p	S88P	0	.	.	262	264	TCC	773	775	TCC	139;138;137	T;C;C	114;117;115	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1040	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3330	93.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1876	1878	GGC	140;142;141	G;G,A;C	118;114,1;121	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2794	101.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1349	1351	GCC	132;131;129	G;C;C	117;113;114	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2794	101.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1352	1354	ATG	129;128;128	A;T;GAA,GA	114;114;110,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2794	101.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1364	1366	ACC	125;125;124	A;C;C	113;111;111	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2794	101.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1364	1366	ACC	125;125;124	A;C;C	113;111;111	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2794	101.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1865	1867	ACC	148;149;148	A;C;C	138;134;139	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2794	101.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1919	1921	GCG	156;155;154	G;C;G	140;142;140	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2794	101.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1919	1921	GCG	156;155;154	G;C;G	140;142;140	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2794	101.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2042	2044	GGT	147;149;149	G,T;G;T	133,1;130;132	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2794	101.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2051	2053	AGC	146;146;147	A;G;C	130;129;130	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2794	101.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2069	2071	CCG	144;142;142	C,A,G;C,G;G,A	110,1,1;118,1;117,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1248	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3439	108.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1792	1794	CCG	127;128;128	C;C,A;G	112;113,1;113	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	644	porA	1146	1146	99.91	porA.l6.c17.ctg.1	2214	86.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	761	761	C	90	C	81	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	750	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2054	109.1	0	.	p	.	0	R144Q	NONSYN	430	432	CGG	957	959	CAG	145;141;143	C;A;G,C	131;131;130,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	750	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2054	109.1	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1155	1157	AGA	152;153;151	A;G;A	139;142;140	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	750	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2054	109.1	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1176	1178	GGT	148;149;150	G;G;T	134;133;135	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	750	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2054	109.1	1	SNP	p	G120K	1	.	.	358	360	AAG	885	887	AAG	154;154;154	A;A;G,C	132;138;132,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	750	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2054	109.1	1	SNP	p	A121N	1	.	.	361	363	AAC	888	890	AAC	153;154;154	A;A;C	133;135;133	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	750	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2054	109.1	1	SNP	p	N121D	0	.	.	361	363	AAC	888	890	AAC	153;154;154	A;A;C	133;135;133	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2378	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5359	133.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	418	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1367	91.0	1	SNP	p	V57M	1	.	.	169	171	ATG	680	682	ATG	156;157;156	A;T;G	142;142;141	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
